Cargando…
Proteomic analysis of platelet-rich and platelet-poor plasma
BACKGROUND: Autologous blood products, such as platelet-rich plasma (PRP) are commercial products broadly used to accelerate healing of tissues after injuries. However, their content is not standardized and significantly varies in composition, which may lead to differences in clinical efficacy. Also...
Autores principales: | Miroshnychenko, Olga, Chalkley, Robert J., Leib, Ryan D., Everts, Peter A., Dragoo, Jason L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770407/ https://www.ncbi.nlm.nih.gov/pubmed/33426223 http://dx.doi.org/10.1016/j.reth.2020.09.004 |
Ejemplares similares
-
The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts: Implications for the Use of Autologous Blood Products for Muscle Regeneration
por: Dragoo, Jason L.
Publicado: (2016) -
Inhibitory Activities of Platelet-Rich and Platelet-Poor Plasma on the Growth of Pathogenic Bacteria
por: Maghsoudi, Omid, et al.
Publicado: (2017) -
Platelet-Poor Plasma as a Supplement for Fibroblasts Cultured in Platelet-Rich Fibrin
por: Chisini, Luiz Alexandre, et al.
Publicado: (2017) -
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
por: Everts, Peter, et al.
Publicado: (2020) -
Leukocyte-Rich Platelet-Rich Plasma Has Better Stimulating Effects on Tenocyte Proliferation Compared With Leukocyte-Poor Platelet-Rich Plasma
por: Lin, Keng-Yi, et al.
Publicado: (2022)